We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

160 hedge funds and large institutions have $176M invested in Emergent Biosolutions in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 40

25% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 28

3% more funds holding

Funds holding: 156 → 160 (+4)

2.48% more ownership

Funds ownership: 64.13% → 66.6% (+2.5%)

1% less call options, than puts

Call options by funds: $944K | Put options by funds: $956K

47% less capital invested

Capital invested by funds: $332M → $176M (-$156M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
160
Holders Change
+4
Holders Change %
+2.56%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
35
Increased
53
Reduced
40
Closed
28
Calls
$944K
Puts
$956K
Net Calls
-$12K
Net Calls Change
-$2.62M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$8.45M
2
LSV Asset Management
LSV Asset Management
Illinois
+$6.7M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$5.23M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.08M
5
PGCM
Prescott Group Capital Management
Oklahoma
+$3.46M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$6.56M
2
Charles Schwab
Charles Schwab
California
-$5.85M
3
Two Sigma Investments
Two Sigma Investments
New York
-$3.72M
4
Morgan Stanley
Morgan Stanley
New York
-$2.98M
5
State Street
State Street
Massachusetts
-$2.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
126
US Bancorp
Minnesota
$3.5K +$3.77K +455 +172%
CIAM
127
Caitong International Asset Management
Hong Kong
$3.02K +$3.73K +450 +263%
GI
128
GAMMA Investing
California
$2.85K -$8.51K -1,028 -64%
AEPWM
129
Atlantic Edge Private Wealth Management
Florida
$2.43K – – –
AG
130
AmeriFlex Group
Nevada
$2.43K +$1.66K +200 +67%
CCM
131
Coldstream Capital Management
Washington
$2.29K +$3.91K +472 New
MPWT
132
MassMutual Private Wealth & Trust
Connecticut
$1.99K – – –
ACM
133
Aquatic Capital Management
Illinois
$1.97K -$188K -22,665 -98%
RBI
134
Raiffeisen Bank International
Austria
$1.94K – – –
CAM
135
Costello Asset Management
Pennsylvania
$1.94K +$3.31K +400 New
Jones Financial Companies
136
Jones Financial Companies
Missouri
$1.93K +$124 +15 +4%
JFA
137
JNBA Financial Advisors
Minnesota
$1.59K – – –
National Bank of Canada
138
National Bank of Canada
Quebec, Canada
$1.17K – – –
RA
139
Rise Advisors
New York
$1.01K +$1.71K +207 New
PS
140
Principal Securities
Iowa
$956 – – –
PWA
141
Physician Wealth Advisors
Utah
$851 +$1.45K +175 New
VCM
142
Versant Capital Management
Arizona
$807 – – –
CFFP
143
Center for Financial Planning
Michigan
$618 – – –
TWC
144
TD Waterhouse Canada
Ontario, Canada
$590 -$538 -65 -34%
Q1WB
145
Quest 10 Wealth Builders
Virginia
$496 – – –
CIAS
146
CBIZ Investment Advisory Services
Ohio
$486 – – –
GC
147
Gould Capital
Washington
$486 – – –
SPIA
148
Steward Partners Investment Advisory
New York
$486 – – –
EWA
149
EverSource Wealth Advisors
Alabama
$418 +$712 +86 New
GWSG
150
GPS Wealth Strategies Group
Colorado
$214 – – –
4 5
6
7 8

EBS Hedge Fund Activity: Q1 2025 in Review

160 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2025, worth a combined $176M — down 47% from $332M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new EBS positions and 28 closed out — a net gain of 7 holders — while 53 added to existing stakes and 40 trimmed.

The largest buyer was Millennium Management, adding an estimated $8.45M. The largest seller was Invesco, cutting an estimated $6.56M.

  • 160 institutional investors held Emergent Biosolutions (EBS) as of Q1 2025, up from 156 in Q4 2024.
  • Funds reported $176M of Emergent Biosolutions stock for Q1 2025, down 47% quarter-over-quarter.
  • 35 funds opened new Emergent Biosolutions positions in Q1 2025 and 28 closed out, a net change of +7 holders.
  • The largest Emergent Biosolutions buyer in Q1 2025 was Millennium Management, an estimated $8.45M added.
  • The largest Emergent Biosolutions seller in Q1 2025 was Invesco, an estimated $6.56M sold.

Based on aggregated 13F filings for Q1 2025.